Search

Author/Creator Trageser, Kyle J.

1. A novel gut microbiome therapeutic derived from dietary polyphenols attenuates neuroinflammation in vivo in a model of c9orf72 mediated frontotemporal dementia: Nonhuman/Target identification and validation studies: Inflammation and innate immunity. (7th December 2020)

Authors:
Trageser, Kyle J.; Smith, Chad; Estill, Molly; Sebastian, Maria; Pasinetti, Giulio Maria
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of 3(3, 4-dihydroxy-phenyl) propionic acid as a novel microbiome-derived epigenetic modifier in attenuation of immune inflammatory response in human monocytes. (September 2020)

Authors:
Wang, Jun; Blaze, Jennifer; Haghighi, Fatemeh; Kim-Schulze, Seunghee; Raval, Urdvha; Trageser, Kyle J.; Pasinetti, Giulio Maria
Journal:
Molecular immunology
Issue:
Volume 125(2020:Sep.)
Page Start:
172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Defining the role of gut microbiota‐derived ketamine metabolites in Alzheimer's disease: Nonhuman/Target identification and validation studies: Inflammation and innate immunity. (7th December 2020)

Authors:
Pasinetti, Giulio Maria; Naughton, Sean X.; Trageser, Kyle J.; Harary, Joyce M.; Westfall, Susan
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search